|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS |
 |
| |
|
|
|
|
| In her Editor’s Letter, Patricia J Lobo takes a look at the topics in this issue |
|
|
|
The health benefits of plants are finally being unlocked, thanks to modern analytical and purification methods, asserts Robert Nash, Research Director at Molecular Nature Limited, in Plant Extracts as Medicines and Sources of New Therapeutic Agents
|
|
|
In Managing for Success in Medical Device Manufacturing, Phil Lever, Head of Device and Manufacturing Services (DMS) at Bespak, discusses the challenges of a successful product launch and its affect on production capacity, and ultimately the supply chain
|
|
|
Mark Bosley, Development Manager at Purite, reviews methods which ensure that standards for highly purified water are met, in Purified Water: An Essential Component for Drug Quality
|
|
|
In Checking Without Contaminating: Detecting Ampoule Microcrack using High-Voltage Technology, Dr Isabelle De Azevedo, Pharmacist at Cenexi Roche, presents one possible method used for pinhole inspection
|
|
|
Bettina Gierszewski, Product Manager at Shimadzu, shows how quality can be maintained for ultra pure water in Wet Chemical or Catalytic Combustion/Oxidation? TOC Determination in the Ultra-Trace Range
|
|
|
|
|
In Trends in Coding and Marking Applications within the Pharmaceutical Sector, James Cutforth, Global Account Manager at Domino Printing Sciences Plc, charts the development of digital coding technologies in providing essential traceability information
|
|
|
| Stefan Schmid, Product Manager at Teich AG, reveals the advantages of using aluminium for packaging material as an anti-counterfeiting device, in Anti-Counterfeiting Features on Aluminium-Based Packaging Material |
|
|
| Michiel van den Berg, Director of Global Pharmaceutical Packaging Development at Tekni-Plex and Bernd Sparenberg, Global Marketing Manager at Ticona, guide us through the reasons for the increasing popularity of blister packaging, in Blister Film Solutions for Drug Protection |
|
|
| Malcolm Little, Managing Director of Advanced Dynamics Limited, shows how labelling can meet the influx of new packaging designs available on the market, in Versatility and Know-How: Pharmaceutical Labellers’ Best Friends |
|
|
Changes are afoot which will alter the packaging of pharmaceuticals. Paul Earnshaw, Principal Consultant of Product & Process Engineering at PA Consulting Group’s Cambridge Technology Centre, is our guide to these new regulations in Pharmaceutical Packaging: Forced or Desired Change?
|
|
|
|
In Powder Flowability – The Impact of Getting it Right, Reg Freeman, Founder and Managing Director of Freeman Technology, underlines the importance of powder form production
|
|
|
The method used for photocopying is being employed in tablet coating.Dominic Griffiths, Director of Business Development at Phoqus Pharmaceuticals Limited, explains how, in Tablet Coating as a Means of Enhancing and Protecting Pharmaceutical Brand Identity
|
|
|
|
In Production and Monitoring of Water for Injection,Tim McDougle, Sales Director at ELGA Process Water, shows why it is crucial that contamination does not occur during the production process
|
|
|
In Targeted and Controlled Release of Cytotoxic Agents: Progress and Obstacles towards the Elusive ‘Magic Bullets’ for Cancer, Roghieh Saffie, Jill Ogden and Leigh Canham at pSiMedica, Pierce Chow, Consultant and Surgeon at Singapore General Hospital, and Roger Aston, Director of Strategy for the pSiVida Group of companies, present a weapon in the battle against cancer
|
|
|
There is hope that innovative drug delivery methods will alter the path of disease – Dr Faiz Kermani, Budgets, Proposals and Marketing Executive at Chiltern International Ltd, illustrates the advances in Finding a Role for Drug Delivery Technologies
|
|
|
Adrian Williams, Professor of Pharmaceutics at the Reading School of Pharmacy at Reading University, maps out the benefits of using skin as the site for treatment in Taking the Transdermal Route: Technological Advances Point to a New Star in Drug Delivery
|
|
|
|
|
Poor patient compliance has potentially disastrous results on the information collated and the outcome of the drug being tested during clinical trials.Martin Lamb, Head of US and EU Business Development at Clinical Trial Services, takes a look at the ways in which this problem can be overcome, in Improving Patient Compliance in Clinical Trials: Smart Packages or Smart Design?
|
|
|
Linda Horton, Partner at Hogan and Harston’s Brussels Office, provides an analysis of the EU Clinical Trials Directive in EU Member States Continue Implementing the Clinical Trials Directive
|
|
|
|
Dr Adam Stoten, Head of Research at Technomark Consulting Services Ltd, charts the rise of generics in India in Consolidate and Conquer: Strategic Acquisitions by Growing Numbers of Indian Pharma are Providing a Springboard for Entry into the European Generics Market
|
|
|
Transparency in the supply chain is of great importance, contends Juan Vertelman, International Sales Manager for the Pharmaceutical Logistics Unit at KLM Cargo, and RFID is a technology that can help ensure that the way forward is smooth, in How Transparent is your Supply Chain?
|
|
|
In Managing the Quality of Security, Dana Kaplan, VP of Marketing and Business Development at InkSure Technologies, reviews the technologies available to meet the demand for authentication of pharma products
|
|
|
Pharmaceutical regulators are raising the bar when it comes to patient safety, and governments now require drug serialisation and pedigrees, explains Brenda Kelly, Vice President of Marketing at SupplyScape, in Securing the Drug Supply from Counterfeiting Protects Brand Profits
|
|
|
|
In PAT: Evolution or Revolution? Charting the Development of Process Analytical Technology, Dr Beatrijs Van Liedekerke, Senior Manager, Enterprise Advisory Department at PricewaterhouseCoopers, states that process analytical technology aids change in the manufacturing sector
|
|
|
Matthias Maaz, European Director of Marketing & Validation for the Life Sciences division of Johnson Controls Inc, assesses the new pressures faced by pharmaceutical manufacturers as a result of FDA alterations regarding risk assessment and 21 CFR Part 11, in Validation Requirements for Building Automation Systems
|
|
|
Microbiological environmental monitoring using risk assessment tools is increasingly required by regulatory authorities, asserts Tim Sandle, Microbiologist at Bio Products Laboratory, in Microbiological Environmental Monitoring in Clean Areas: Using Risk Assessment
|
|
|
|
Patricia J Lobo, Editor of PMPS, looks forward to the forthcoming Bio/PharMOS-Bio/PharDOS 2005, which takes place on 22nd-23rd March
|
|
|
|
|
Pharmaceutical manufacturing processes suffer from many problems, including poor design and poor management, contend Mark Lansley and Dr Brian Watson at Breakthrough Management Group, and Six Sigma is a method which can overcome these inadequacies, as outlined in Statistical Tolerancing: A Valuable Design for Six Sigma Tool for Pharmaceutical Manufacturing
|
|
|
How can packaging technology be developed in order to combat the issue of counterfeiting? Julian Mount, European Director of Trade at Pfizer, presents the dilemma, in Patient Safety must be the Key Driver in Packaging
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform
PITTSBURGH, PA, Dec. 21, 2020 /PRNewswire/ -- Peptilogics announced today the closing of a $35.4 million Series B financing. The financing was led by Presight Capital, with participation from a new investor syndicate including Founders Fund as well as from existing investor Peter Thiel. The proceeds of the financing will be used to expand Peptilogics’ computational platform and invest in technologies to improve its drug design engine, as well as accelerate development of a pipeline of peptide therapeutics including the Company’s lead clinical asset, PLG0206, which has demonstrated first-in-class safety and best-in-class efficacy.
More info >> |
|
 |
White Papers |
 |
|
Future-proofing serialization solutions: the importance of strong level 3 capabilities
Adents
The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >> |
|
|
.jpg)
